Related Experiment Video
Updated: Aug 22, 2025

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Anti-influenza A virus activity of flavonoids in vitro: a structure-activity relationship
Ryosuke Morimoto1,2, Akari Hanada1, Chiaki Matsubara1
1Department of Food Sciences and Nutrition, School of Food Sciences and Nutrition, Mukogawa Women's University, Ikebiraki-cho 6-46, Nishinomiya, Hyogo, 663-8558, Japan.
Abstract:
Secondary plant metabolites from food extracts, namely daidzein, quercetin, and luteolin, exhibit anti-influenza virus effects, with IC50 values of 143.6, 274.8, and 8.0 μM, respectively. The activities of these metabolites differ depending on the functional groups. Therefore, in this study, we focused on members of the flavonoid group, and investigated the anti-influenza viral effects of different flavonoid classes (flavone, isoflavone, flavonol, flavanone, and flavan-3-ol) in vitro. The IC50 values were 4.9-82.8 μM, 143.6 μM, 62.9-477.8 μM, 290.4-881.1 μM, and 22.9-6717.2 μM, respectively, confirming their activity. The modifying group factors (number, position, type) in the flavonoid skeleton may be significantly related to the anti-influenza virus activity. Moreover, time-of-addition assay revealed that the mechanism of inhibition varied for the different classes; for example, flavonoids that inhibit virus adsorption or the early stage of viral growth. Interestingly, all the examined flavonoids inhibited the late stages of viral growth, suggesting that flavonoids mainly inhibit the late events in viral growth before the release of viral particles. Additionally, apigenin might be effective against oseltamivir-resistant strains. Our results may be important in the development of anti-influenza virus therapeutic strategies in the future.
More Related Videos
12:02Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017